| Document and Entity Information | 6 Months Ended | |
| Nov. 30, 2013 | Jan. 14, 2014 | |
| Document and Entity Information: | ' | ' |
| EntityRegistrantName | 'RAMBO MEDICAL GROUP, INC. | ' |
| DocumentType | '10-Q | ' |
| DocumentPeriodEndDate | 30-Nov-13 | ' |
| AmendmentFlag | 'false | ' |
| EntityCentralIndexKey | '0001350421 | ' |
| CurrentFiscalYearEndDate | '--05-31 | ' |
| EntityCommonStockSharesOutstanding | ' | 992,192 |
| EntityFilerCategory | 'Smaller Reporting Company | ' |
| EntityCurrentReportingStatus | 'Yes | ' |
| EntityVoluntaryFilers | 'No | ' |
| EntityWellKnownSeasonedIssuer | 'No | ' |
| DocumentFiscalYearFocus | '2014 | ' |
| DocumentFiscalPeriodFocus | 'Q2 | ' |
| CONDENSED BALANCE SHEETS (USD $) | Nov. 30, 2013 | 31-May-13 |
| Current assets | ' | ' |
| Cash and cash equivalent | $9,621 | $4,458 |
| Total assets (all current) | 9,621 | 4,458 |
| Current liabilities | ' | ' |
| Accounts payable | 35,350 | 10,791 |
| Accounts payable - related parties | 0 | 0 |
| Accrued expense | 1,000 | 0 |
| Loans payable (current portion) | 65,000 | 55,000 |
| Total current liabilities | 101,350 | 65,791 |
| Loans payable (non-current portion) | 0 | 0 |
| Total liabilities | 101,350 | 65,791 |
| Stockholders' equity | ' | ' |
| Preferred stock, $.00001 par value; 100,000,000 shares authorized; no shares issued or outstanding | 0 | 0 |
| Common stock, $.00001 par value; 300,000,000 authorized; 992,192 shares issued and outstanding as of November 30, 2013 and May 31, 2013 | 991 | 991 |
| Additional paid in capital | 7,043,222 | 7,043,222 |
| Deficit accumulated during development stage | -7,135,942 | -7,105,546 |
| Total stockholders' equity | -91,729 | -61,333 |
| Total liabilities and stockholders' equity | $9,621 | $4,458 |
| BALANCE SHEET PARENTHETICALS (USD $) | Nov. 30, 2013 | 31-May-13 |
| Parentheticals | ' | ' |
| Preferred Stock, par value | $0.00 | $0.00 |
| Preferred Stock, shares authorized | 100,000,000 | 100,000,000 |
| Common Stock, par value | $0.00 | $0.00 |
| Common Stock, shares authorized | 300,000,000 | 300,000,000 |
| Common Stock, shares issued | 992,192 | 992,192 |
| Common Stock, shares outstanding | 992,192 | 992,192 |
| CONDENSED STATEMENT OF OPERATIONS (USD $) | 3 Months Ended | 6 Months Ended | 96 Months Ended | ||
| Nov. 30, 2013 | Nov. 30, 2012 | Nov. 30, 2013 | Nov. 30, 2012 | Nov. 30, 2013 | |
| Revenue: | ' | ' | ' | ' | ' |
| Revenue | $0 | $0 | $0 | $0 | $0 |
| Operating expenses | ' | ' | ' | ' | ' |
| General and administrative expenses | 14,270 | 12,677 | 30,396 | 23,437 | 7,118,833 |
| Total operating expenses | 14,270 | 12,677 | 30,396 | 23,437 | 7,118,833 |
| Loss from operations | -14,270 | -12,677 | -30,396 | -23,437 | -7,118,833 |
| Other income / (expenses) | ' | ' | ' | ' | ' |
| Other income | 0 | 0 | 0 | 0 | 1,509 |
| Loss on disposal of office equipments | 0 | 0 | 0 | 0 | -1,592 |
| Interest expenses | 0 | 0 | 0 | 0 | -17,026 |
| Total other income / (expense) | 0 | 0 | 0 | 0 | -17,109 |
| Net loss | ($14,270) | ($12,677) | ($30,396) | ($23,437) | ($7,135,942) |
| Basic and diluted loss per common shares | ($0.01) | ($0.01) | ($0.03) | ($0.02) | ' |
| Weighted average shares outstanding | 992,192 | 992,192 | 992,192 | 992,192 | ' |
| CONDENSED STATEMENT OF CASH FLOWS (USD $) | 6 Months Ended | 96 Months Ended | |
| Nov. 30, 2013 | Nov. 30, 2012 | Nov. 30, 2013 | |
| Cash flows from operating activities | ' | ' | ' |
| Net loss | ($30,396) | ($23,437) | ($7,135,942) |
| Adjustments to reconcile net loss to net cash provided by (used in) operating activities: | ' | ' | ' |
| Donated office space and services | 0 | 0 | 13,500 |
| Depreciation | 0 | 0 | 1,304 |
| Exploration costs - lease write downs | 0 | 0 | 5,339,871 |
| Compensatory stock issuances | 0 | 0 | 317,000 |
| Changes operating assets and liabilities: | ' | ' | ' |
| Other assets | 0 | 0 | 0 |
| Accounts payable | 24,559 | 14,188 | 43,647 |
| Accounts payable - related parties | 0 | 0 | 0 |
| Accrued interest / expense | 1,000 | 0 | 1,000 |
| Net cash provided by (used in) operating activities | -4,837 | -9,249 | -1,419,620 |
| Cash flows from investing activities | ' | ' | ' |
| Purchase of equipment and furniture | 0 | 0 | -2,896 |
| Loss on disposal of equipment and furniture | 0 | 0 | 1,592 |
| Oil and gas properties | 0 | 0 | -691,871 |
| Net cash used in investing activities | 0 | 0 | -693,175 |
| Cash flows from financing activities | ' | ' | ' |
| Common stock issued for cash | 0 | 0 | 1,940,450 |
| Proceeds from loans | 10,000 | 0 | 181,966 |
| Net cash provided by financing activities | 10,000 | 0 | 2,122,416 |
| Net change in cash and cash equivalents | 5,163 | -9,249 | 9,621 |
| Cash and cash equivalents at the beginning of period | 4,458 | 12,238 | 0 |
| Cash and cash equivalents at the end of period | 9,621 | 2,989 | 9,621 |
| Supplemental disclosure of cash flow information: | ' | ' | ' |
| Cash paid for interest | 0 | 0 | 0 |
| Cash paid for income taxes | $0 | $0 | $0 |
| CONDENSED FINANCIAL STATEMENTS | 6 Months Ended |
| Nov. 30, 2013 | |
| CONDENSED FINANCIAL STATEMENTS | ' |
| CONDENSED FINANCIAL STATEMENTS | ' |
| NOTE 1. CONDENSED FINANCIAL STATEMENTS | |
| The accompanying financial statements have been prepared by the Company without audit. In the opinion of management, all adjustments (which include only normal recurring adjustments) necessary to present fairly the financial position, results of operations, and cash flows on November 30, 2013, and for all periods presented herein, have been made. | |
| Certain information and footnote disclosures normally included in the financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted. It is suggested that these condensed financial statements be read in conjunction with the financial statements and notes thereto included in the Company’s May 31, 2013 and 2012 audited financial statements. The results of operations for the six months ended November 30, 2013 are not necessarily indicative of the operating results for the full year. |
| GOING CONCERN | 6 Months Ended |
| Nov. 30, 2013 | |
| GOING CONCERN | ' |
| GOING CONCERN | ' |
| NOTE 2. GOING CONCERN | |
| Under the going concern assumption, an entity is ordinarily viewed as continuing in business for the foreseeable future with neither the intention nor the necessity of liquidation, ceasing trading, or seeking protection from creditors pursuant to laws or regulations. Accordingly, assets and liabilities are recorded on the basis that the entity will be able to realize its assets and discharge its liabilities in the normal course of business. | |
| The future of the Company is dependent upon its ability to obtain financing and upon future profitable operations from the development of its planned business. Management has plans to seek additional capital through a public or private offering of equity or debt securities, or by other means. These conditions raise substantial doubt about the Company's ability to continue as a going concern. These financial statements do not include any adjustments that might arise from this uncertainty. | |
| There can be no assurance that sufficient funds required during the next year or thereafter will be generated from operations or that funds will be available from external sources such as debt or equity financings or other potential sources. The lack of additional capital resulting from the inability to generate cash flow from the operations or to raise capital from external sources would force the Company to substantially curtail or cease operations and would, therefore, have a material adverse effect on its business. Furthermore, there can be no assurance that any such required funds, if available, will be available on attractive terms or that they will not have a significant dilutive effect on the Company's existing shareholders. | |
| The financial statements do not include any adjustments relating to the recoverability and classification of recorded assets, or the amounts of and classification of liabilities that might be necessary in the event the Company cannot continue in existence. |
| LOAN PAYABLE | 6 Months Ended |
| Nov. 30, 2013 | |
| LOAN PAYABLE | ' |
| LOAN PAYABLE | ' |
| NOTE 3. LOAN PAYABLE | |
| On February 28, 2013, the company took a loan from American Compass Inc. in the amount of $20,000. This is a 5% interest bearing and unsecured loan due on June 30, 2013. On April 18, 2013, the Company accepted another loan from American Compass Inc. in the amount of $5,000. This is a non-interest bearing and unsecured loan due on June 30, 2013. | |
| The due date of the loan were extended and the new date is yet to be determined. | |
| On November 4, 2013 the company took another loan from ACI in the amount of $10,000. This is a non-interest bearing and unsecured loan. The loan does not have a maturity date. |
| ACCOUNTS PAYABLE | 6 Months Ended |
| Nov. 30, 2013 | |
| ACCOUNTS PAYABLE | ' |
| ACCOUNTS PAYABLE | ' |
| NOTE 4. ACCOUNTS PAYABLE | |
| During the first quarter, American Compass Inc. has paid legal fees for the company in the amount of $15,333. As of August 31, American Compass Inc. has paid total of $25,332 for the company which consists of mainly legal and auditing cost. | |
| During the second quarter, American Compass Inc. paid $7,527 in legal fees and $1,000 in auditing fees for the company. As of November 30, the balance of payable to ACI is $33,859. |
| COMMON STOCK | 6 Months Ended |
| Nov. 30, 2013 | |
| COMMON STOCK | ' |
| COMMON STOCK | ' |
| NOTE 5. COMMON STOCK | |
| The Company is authorized to issue 100,000,000 shares of preferred stock with a par value of $.00001 per share. The Company is also authorized to issue 300,000,000 shares of common stock with a par value of $.00001 per share. On May 6, 2008, the Company effected a forward split of 35 for each share of common stock. On July 20, 2010, the Company issued 50,000 shares of common stock to investors at a price of $2 per share for a total of $100,000. The Company had issued a total of 150,000 shares of common stock to compensate its officers during the fiscal year of 2012. There were 992,192 and 991,162 shares issued and outstanding as of November 30, 2013 and August 31, 2012 respectively. | |
| Effective April 25, 2011, Massimiliano Pozzoni sold 350,000 shares of common stock held in his name to Chimerica Capital, LLC. Jimmy Wang, the Company’s treasurer, has the power to vote and dispose of the shares transferred to Chimerica Capital, LLC. |
| OFFICE LEASE | 6 Months Ended |
| Nov. 30, 2013 | |
| OFFICE LEASE | ' |
| OFFICE LEASE | ' |
| NOTE 6. OFFICE LEASE | |
| Commencing in May 2011, the company was no longer a party to a lease agreement. The Company uses an office at a location provided by one of its officers rent-free. |
| NAME CHANGE AND RECAPITALIZATION | 6 Months Ended |
| Nov. 30, 2013 | |
| NAME CHANGE AND RECAPITALIZATION | ' |
| NAME CHANGE AND RECAPITALIZATION | ' |
| NOTE 7. NAME CHANGE AND RECAPITALIZATION | |
| On August 8, 2013, the Company approved a name change to Rambo Medical Group, Inc. and a 1-for-100 reverse split of its outstanding common stock. The accompanying financial statements and notes to the financial statements give retroactive effect to the reverse stock split for all periods presented. |
| COMMITMENTS AND CONTINGENCIES | 6 Months Ended |
| Nov. 30, 2013 | |
| COMMITMENTS AND CONTINGENCIES | ' |
| COMMITMENTS AND CONTINGENCIES | ' |
| NOTE 8. COMMITMENTS AND CONTINGENCIES | |
| The Company could become a party to various legal actions arising in the ordinary course of business. Matters that are probable of unfavorable outcomes to the Company and which can be reasonably estimated are accrued. Such accruals are based on information known about the matters, the Company’s estimates of the outcomes of such matters and its experience in contesting, litigating and settling similar matters. | |
| As of the date of this annual report, there are no material pending legal proceedings to which the Company is a party or of which any of their property is the subject, nor are there any such proceedings known to be contemplated by governmental authorities. |
| SUBSEQUENT EVENTS | 6 Months Ended |
| Nov. 30, 2013 | |
| SUBSEQUENT EVENTS | ' |
| SUBSEQUENT EVENTS | ' |
| NOTE 9. SUBSEQUENT EVENTS | |
| The Company evaluated all events or transactions that occurred after November 30, 2013 through the date of this filing in accordance with FASB ASC 855 “Subsequent Events” and has determined that there were no subsequent events required to be disclosed. |
| LOAN PAYABLE TRANSACTIONS (Details) (USD $) | Nov. 04, 2013 | Jun. 30, 2013 | Apr. 18, 2013 |
| LOAN PAYABLE TRANSACTIONS: | ' | ' | ' |
| Loan from American Compass Inc., | ' | $20,000 | ' |
| Accepted another loan from American Compass Inc | ' | ' | 5,000 |
| Unsecured loan interest per annum | ' | 5.00% | ' |
| loan from ACI in the amount | $10,000 | ' | ' |
| ACCOUNTS PAYABLE TRANSACTIONS (Details) (USD $) | 3 Months Ended | 6 Months Ended | |
| Nov. 30, 2013 | Nov. 30, 2013 | Aug. 31, 2013 | |
| ACCOUNTS PAYABLE TRANSACTIONS: | ' | ' | ' |
| Paid legal fee in the amount | $15,333 | ' | ' |
| American Compass Inc. has paid total | ' | ' | 25,332 |
| American Compass Inc. paid legal fee | ' | 7,527 | ' |
| Paid auditing fee | ' | 1,000 | ' |
| Balance of payable to ACI | $33,859 | $33,859 | ' |
| COMMON STOCK TRANSACTIONS (Details) (USD $) | Nov. 30, 2013 | Aug. 31, 2013 | Apr. 25, 2011 | Jul. 20, 2010 |
| COMMON STOCK TRANSACTIONS: | ' | ' | ' | ' |
| Preferred stock shares issued | 100,000,000 | ' | ' | ' |
| Preferred stock shares par value | $0.00 | ' | ' | ' |
| Common stock issued shares | 300,000,000 | ' | ' | 50,000 |
| Common stock shares par value | $0.00 | ' | ' | $2 |
| Common stock shares value | ' | ' | ' | $100,000 |
| Shares issued and outstanding | 992,192 | 991,162 | ' | ' |
| Massimiliano Pozzoni sold shares of common stock | ' | ' | 350,000 | ' |
| Company issued a total of shares of common stock to compensate its officers in millions | ' | 0.15 | ' | ' |
